The mutational landscape of phosphorylation signaling in cancer.
about
Classification of intrinsically disordered regions and proteinsStatistical Methods for Establishing Personalized Treatment Rules in OncologyNext-generation sequencing: hype and hope for development of personalized radiation therapy?Evolutionary constraint and disease associations of post-translational modification sites in human genomesTurnover of protein phosphorylation evolving under stabilizing selectionPrediction of Functionally Important Phospho-Regulatory Events in Xenopus laevis Oocytes.Comprehensive identification of mutational cancer driver genes across 12 tumor types.Pan-cancer analysis for studying cancer stage using protein expression dataMUFFINN: cancer gene discovery via network analysis of somatic mutation data.Toward a systematic understanding of cancers: a survey of the pan-cancer studyOncodriveROLE classifies cancer driver genes in loss of function and activating mode of actionBioinformatics study of cancer-related mutations within p53 phosphorylation site motifsHuman germline and pan-cancer variomes and their distinct functional profilesIntegrating phosphoproteomics in systems biology.MSEA: detection and quantification of mutation hotspots through mutation set enrichment analysisThe Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.ATR-FTIR spectroscopy for the assessment of biochemical changes in skin due to cutaneous squamous cell carcinoma.An improved understanding of cancer genomics through massively parallel sequencing.GreedyPlus: An Algorithm for the Alignment of Interface Interaction Networks.Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.Systematic analysis of somatic mutations impacting gene expression in 12 tumour types.E2 superfamily of ubiquitin-conjugating enzymes: constitutively active or activated through phosphorylation in the catalytic cleft.Nonsynonymous Single-Nucleotide Variations on Some Posttranslational Modifications of Human Proteins and the Association with DiseasesDriverDBv2: a database for human cancer driver gene research.Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)Colorectal cancer risk genes are functionally enriched in regulatory pathways.Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomesPan-Cancer Analysis of Mutation Hotspots in Protein Domains.Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features.Identification of IDUA and WNT16 Phosphorylation-Related Non-Synonymous Polymorphisms for Bone Mineral Density in Meta-Analyses of Genome-Wide Association Studies.Towards single-cell LC-MS phosphoproteomics.Uncovering Phosphorylation-Based Specificities through Functional Interaction Networks.Integration of structural dynamics and molecular evolution via protein interaction networks: a new era in genomic medicine.Computational approaches for the identification of cancer genes and pathwaysMethods, Tools and Current Perspectives in Proteogenomics.PhosphoPICK-SNP: quantifying the effect of amino acid variants on protein phosphorylation.PIN1 in breast development and cancer: a clinical perspective.Regulatory elements in molecular networks.Computational analyses of the effect of novel amino acid clusters of human transglutaminase 2 on its structure and function.
P2860
Q22061736-5D5F3D40-46A4-4842-B698-B70FFE6CA095Q26786366-A71E7BD6-9B8A-4E05-B756-893900A02F94Q26796485-9EAA9C78-03ED-4C4F-A180-9D0D7E47A1BAQ28543059-75BC4D13-2FAF-4D17-8F42-08B4147C40D1Q28655434-2CA19C0D-FDBA-409D-B89F-00F2E4071FF7Q30378436-9B90F306-43EC-4560-B008-F46CD2799285Q30547820-E1FA7F81-A668-4768-BA13-BB7D5D8C65A8Q31035525-6C8E8DBB-02BD-4CD1-AD81-F76BF3328CECQ31110093-4516DA17-2686-4114-8EA3-4FC33A39EA0AQ33840041-63373AC9-4857-4D00-83FF-2561C404DF6BQ34103213-2294A9E2-34F0-463B-B5BD-AD54A54B625BQ34158315-F8734A2D-5A85-4227-8E20-C9D3BF5FBF54Q34312953-55E53EDA-4861-4F13-991B-658241B07213Q34377093-14D70B32-BF86-4F2A-9033-C8B2D78F3A49Q34484638-6238454C-9BD6-480A-9976-8D17048520BAQ35066321-89758508-1906-487C-8AAA-D8116324F9E5Q35585372-2B4E925A-E5DA-4DA9-AAE2-BAEF882B9670Q35801066-F1F80A60-26AA-4592-A7EB-7F860E98DD55Q35844486-424F5237-034A-4530-B9DC-3A6FF793B1C0Q36086246-39015577-7624-492E-835A-74B720423D2FQ36145927-F0604050-24DB-4E97-B446-721B6FAB15F6Q36158657-B39A13C5-5679-4404-A017-F47E9401B3E5Q36162600-201D1C29-6076-4DE2-97EC-8E1D4E9A16CBQ36435002-6A9C8622-0544-441B-BE14-2AE93A050485Q36748138-3FAA42BA-99FC-46BA-B3F5-BB2131ADC170Q36871098-BB7E5168-2854-459A-B6F9-E29D326FCBEEQ36895438-681A6486-860E-40B1-8542-B5BB652C73D4Q37096363-951A1790-EB03-4DC4-B442-D3A3F54ECF9FQ37170860-0212A3B9-97A3-4848-85A3-46B741D8ABB3Q37609524-A5B67EAF-521E-4D3F-AD45-BA2FC33C6402Q37716328-A4247DBC-E187-41E5-A6F2-E81575E7782FQ38234569-218D5EC0-7CB7-401C-8FAA-E2F2986EF788Q38587557-2B1CB21B-E82D-4B69-BD39-FE8699451D26Q38673851-1F0215A2-074E-4FD8-B949-338A22BF05C1Q38793593-E6038172-A103-40DC-B365-2402B657EAF5Q38812665-79F9C06F-6DD1-4893-8835-373C04DF7F2BQ38967834-0D329375-FA97-405F-9EC1-E75ECF09ED0DQ39005373-FC491A8C-3C85-4C11-A55D-1E0C220BEDF2Q39091526-862861C7-E01C-4266-A42D-BE2A541E98C1Q39390772-56ABCB33-9C10-4A0A-9A47-54D83ABCBD82
P2860
The mutational landscape of phosphorylation signaling in cancer.
description
2013 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
The mutational landscape of phosphorylation signaling in cancer.
@en
The mutational landscape of phosphorylation signaling in cancer.
@nl
type
label
The mutational landscape of phosphorylation signaling in cancer.
@en
The mutational landscape of phosphorylation signaling in cancer.
@nl
prefLabel
The mutational landscape of phosphorylation signaling in cancer.
@en
The mutational landscape of phosphorylation signaling in cancer.
@nl
P2860
P50
P356
P1433
P1476
The mutational landscape of phosphorylation signaling in cancer.
@en
P2860
P2888
P356
10.1038/SREP02651
P407
P577
2013-10-02T00:00:00Z
P5875
P6179
1038257771